Diminished Virulence Of A Sar-lagr- Mutant Of Staphylococcus Aureus In The Rabbit Model Of Endocarditis

Microbial pathogenicity in Staphylococcus aureus is a complex process involving a number of virulence genes that are regulated by global regulatory systems including sar and agr. To evaluate the roles of these two loci in virulence, we constructed sar-lagr- mutants of strains RN6390 and RN450 and compared their phenotypic profiles to the corresponding single sar- and agr- mutants and parents. The secretion of all hemolysins was absent in the sar-lagr- mutants while residual β-hemolysin activity remained in single agr- mutants. The fibronectin binding capacity was significantly diminished in both single sar- mutants and double mutants when compared with parents while the reduction in fibrinogen binding capacity in the double mutants was modest. In the rabbit endocarditis model, there was a significant decrease in both infectivity rates and intravegetation bacterial densities with the double mutant as compared to the parent (RN6390) at 103-106 CFU inocula despite comparable levels of early bacteremia among various challenge groups. Notably, fewer bacteria in the double mutant group adhered to valvular vegetations at 30 min after challenge (106 CFU) than the parent group. These studies suggest that both the sar and agr loci are involved in initial valvular adherence, intravegetation persistence and multiplication of S. aureus in endocarditis.94518151822Waldvogel, F.A., Staphylococcus aureus (1985) Principles and Practice of Infectious Diseases, pp. 1097-1116. , G. L. Mandell, R. G. Douglas, Jr., and J. E. Bennett, editors. John Wiley & Sons, New YorkNeu, H.C., The crisis in antibiotic resistance (1992) Science (Wash. DC), 257, pp. 1064-1072Cohen, M.L., Epidemiology of drug resistance: Implications for a post-antibiotic era (1992) Science (Wash. DC), 257, pp. 1050-1055Easmon, C.S.F., Adlam, C., (1983) Staphylococci and Staphylococcal Infections, pp. 705-740. , Academic Press, New YorkCheung, A.L., Krishnan, M., Jaffe, E.A., Fischetti, V.A., Fibrinogen acts as a bridging molecule in the adherence of Staphylococcus aureus to cultured human endothelial cells (1991) J. Clin. Invest., 87, pp. 2236-2245Herrmann, M., Vaudaux, P.E., Pittet, D., Auckenthaler, R., Lew, P.D., Schumacher Perdreau, F., Peters, G., Waldvogel, F.A., Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material (1988) J. Infect. Dis., 158, pp. 693-701Kuypers, J.M., Proctor, R.A., Reduced adherence to traumatized rat heart valves by a low-fibronectin-binding mutant of Staphylococcus aureus (1989) Infect. Immun., 57, pp. 2306-2312DeRita, V.J., Mekalanos, J.J., Genetic regulation of bacterial virulence (1989) Annu. Rev. Genet., 23, pp. 455-482Kornblum, J., Kreiswirth, B., Projan, S.J., Ross, H., Novick, R.P., Agr: A polycistronic locus regulating exoprotein synthesis in Staphylococcus aureus (1990) Molecular Biology of the Staphylococci, pp. 373-402. , R. P. Novick, editor. VCH Publishers, New YorkNixon, B.T., Ronson, C.W., Ausubel, R.M., Two component regulatory systems responsive to environmental stimuli share strongly conserved domains with the nitrogen assimilation regulatory genes ntrB and btrC (1986) Proc. Natl. Acad. Sci. USA, 83, pp. 7850-7854Smeltzer, M.S., Hart, M.E., Iandolo, J.J., Phenotypic characterization of xpr, a global regulator of extracellular virulence factors in Staphylococcus aureus (1993) Infect. Immun., 61, pp. 919-925Cheung, A.L., Koomey, J.M., Butler, C.A., Projan, S.J., Fischetti, V.A., Regulation of exoprotein expression in Staphylococcus aureus by a locus (sar) distinct from agr (1992) Proc. Natl. Acad. Sci. USA, 89, pp. 6462-6466Cheung, A.L., Yeaman, M., Bayer, A.S., The role of the sar locus of Staphylococcus aureus in the induction of endocarditis in rabbits (1994) Infect. Immun., 62, pp. 1719-1725Vandenesch, F., Kornblum, J., Novick, R.P., A temporal signal, independent of agr, is required for hla but not spa transcription in Staphylococcus aureus (1991) J. Bacteriol., 173, pp. 6313-6320Cheung, A.L., Ying, P., Regulation of α and β hemolysins by the sar locus of Staphylococcus aureus (1994) J. Bacteriol., 176, pp. 580-585Rescei, P., Kreiswirth, B., O'Reilly, M., Schlievert, P., Gruss, A., Novick, R.P., Regulation of exoprotein gene expression in Staphylococcus aureus by agr (1986) Mol. & Gen. Genet., 202, pp. 58-61Fröman, G., Switalski, L., Speziale, P., Höök, M., Isolation and characterization of a fibronectin receptor from Staphylococcus aureus (1987) J. Biol. Chem., 262, pp. 6564-6571Lantz, M., Allen, R.D., Bounelis, P., Switalski, L.M., Höök, M., Bacteroides gingivalis and Bacteroides intermedius recognize different sites on human fibrinogen (1990) J. Bacteriol., 172, pp. 716-726Yeaman, M.R., Sullam, P.M., Dazin, P.F., Norman, D.C., Bayer, A.S., Characterization of Staphylococcus aureus-platelet binding by quantitative flow cytometric analysis (1992) J. Infect. Dis., 166, pp. 65-73Clawson, C.C., White, J.G., Herzberg, M.C., Platelet interaction with bacteria. VI. Contrasting the role of fibrinogen and fibronectin (1980) Am. J. Hematol., 9, pp. 43-53Yeaman, M.R., Norman, D.C., Bayer, A.S., Staphylococcus aureus susceptibility to thrombin-induced platelet microbicidal protein is independent of platelet adherence and aggregation in vitro (1992) Infect. Immun., 60, pp. 2368-2374Sullam, P.M., Payan, D.G., Dazin, P.F., Valone, F.H., Binding of viridans group streptococci to human platelets: A quantitative analysis (1990) Infect. Immun., 58, pp. 3802-3806Yeaman, M.R., Puentes, S.M., Norman, D.C., Bayer, A.S., Partial characterization and staphylocidal activity of thrombin-induced platelet microbicidal protein (1992) Infect. Immun., 60, pp. 1202-1209Kornblum, J., Projan, S.J., Moghazeh, S.L., Novick, R., A rapid method to quantitate non-labeled RNA species in bacterial cells (1988) Gene, 63, pp. 75-85Maniatis, T., Fritsch, E.F., Sambrook, J., (1989) Molecular Cloning, a Laboratory Manual, , Cold Spring Harbor Laboratory, Cold Spring Harbor, NYDurack, D.T., Beeson, P.B., Experimental bacterial endocarditis. I. Colonization of a sterile vegetation (1972) Br. J. Exp. Pathol., 53, pp. 44-49Scheld, W.M., Valone, J.A., Sande, M.A., Bacterial adherence in the pathogenesis of endocarditis. Interaction of bacterial dextran, platelets and fibrin (1978) J. Clin. Invest., 61, pp. 1394-1404Herzberg, M.C., Gong, K., McMarlane, G.D., Phenotypic characterization of Streptococcus sanguis virulence factors associated with bacterial endocarditis (1990) Infect. Immun., 58, pp. 515-522Cheung, A.L., Fischetti, V.A., The role of fibrinogen in staphylococcal adherence to catheters in vitro (1990) J. Infect. Dis., 161, pp. 1177-1186Herrmann, M., Vaudaux, P.E., Pittet, D., Auckenthaler, R., Lew, P.D., Schumacher Perdreau, F., Peters, G., Waldvogel, F.A., Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material (1988) J. Infect. Dis., 158, pp. 693-701Cheung, A.L., Projan, S.J., Cloning and sequencing of sarA: A gene required for the expression of agr (1994) J. Bacteriol., 176, pp. 4168-4172Scheld, W.M., Strunk, R.W., Balian, G., Calderone, R.A., Microbial adhesion to fibronectin in vitro correlates with production of endocarditis in rabbits (1985) Proc. Soc. Exp. Biol. Med., 180, pp. 474-482Durack, D.T., Beeson, P.B., Pathogenesis of infective endocarditis (1980) Infective Endocarditis, pp. 1-53. , S. H. Rahimtoola, editor. Grune and Stratton, Inc., New YorkJaffe, E., Cell biology of endothelial cells (1987) Hum. Pathol., 18, pp. 234-239Lopes, J.D., Reis, M.D., Bretani, R.R., Presence of laminin receptors in Staphylococcus aureus (1985) Science (Wash. DC), 229, pp. 275-277Patti, J.M., Bremell, T., Krajewska-Paetrasik, D., Adelnour, A., Tarkowski, A., Ryden, C., Höök, M., The Staphylococcus aureus collagen adhesin is a virulence determinant in experimental septic arthritis Infect. Immun., 62, pp. 152-161Herrmann, M., Suchard, S.J., Boxer, L.A., Waldvogel, F.A., Lew, P.D., Thrombospondin binds to Staphylococcus aureus and promotes staphylococcal adhesion to surfaces (1991) Infect. Immun., 59, pp. 279-288Bhakdi, S., Muhly, M., Mannhardt, U., Hugo, F., Klapettek, K., Muller-Eckhardt, C., Roka, L., Staphylococcal α-toxin promotes blood coagulation via attack on human platelets (1988) J. Exp. Med., 168, pp. 527-542Suttorp, N., Hessz, T., Seeger, W., Wilke, A., Koob, R., Lutz, F., Drenckhahn, D., Bacterial exotoxins and endothelial permeability for water and albumin in vitro (1988) Am. J. Physiol., 255, pp. C368Novick, R.P., Genetic systems in staphylococci (1991) Methods Enzymol., 204, pp. 587-636O'Reilly, M., De Azavedo, J.C.S., Kennedy, S., Foster, T.J., Inactivation of the alpha-hemolysin of Staphylococcus aureus 8325-4 by site directed mutagenesis and studies on the expression of its haemolysins (1986) Microb. Pathog., 1, pp. 125-138Projan, S.J., Kornblum, J., Kreiswirth, B., Moghazeh, S., Eisner, W., Novick, R.P., The β hemolysin gene of Staphylococcus aureus (1989) Nucleic Acids Res., 17, p. 3305Camilli, A., Portnoy, D.A., Youngman, P., Insertional mutagenesis of Listeria monocytogenes with a novel Tn917 derivative that allows direct cloning of DNA flanking transposon insertions (1990) J. Bacteriol., 172, pp. 3738-3744Nesin, M., Svec, P., Lupski, J.R., Godson, G.N., Kreiswirth, B., Kornblum, J., Projan, S.J., Cloning and nucleotide sequencing of a chromosomally encoded tetracycline resistance determinant, tetA(M), from a pathogenic, methicillin resistant strain of Staphylococcus aureus (1990) Antimicrob. Agents Chemother., 34, pp. 2273-227

Update on biomarkers in neuromyelitis optica

Neuromyelitis optica (NMO) (and NMO spectrum disorder) is an autoimmune inflammatory disease of the CNS primarily affecting spinal cord and optic nerves. Reliable and sensitive biomarkers for onset, relapse, and progression in NMO are urgently needed because of the heterogeneous clinical presentation, severity of neurologic disability following relapses, and variability of therapeutic response. Detecting aquaporin-4 (AQP4) antibodies (AQP4-IgG or NMO-IgG) in serum supports the diagnosis of seropositive NMO. However, whether AQP4-IgG levels correlate with disease activity, severity, response to therapy, or long-term outcomes is unclear. Moreover, biomarkers for patients with seronegative NMO have yet to be defined and validated. Collaborative international studies hold great promise for establishing and validating biomarkers that are useful in therapeutic trials and clinical management. In this review, we discuss known and potential biomarkers for NMO

Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide

Neuromyelitis optica spectrum disorder (NMOSD) is an uncommon inflammatory disease of the central nervous system, manifesting clinically as optic neuritis, myelitis, and certain brain and brainstem syndromes. Cases clinically diagnosed as NMOSD may include aquaporin 4 (AQP4)-antibody-seropositive autoimmune astrocytopathic disease, myelin oligodendrocyte glycoprotein (MOG)-antibody-seropositive inflammatory demyelinating disease, and double-seronegative disease. AQP4-antibody disease has a high female-to-male ratio (up to 9:1), and its mean age at onset of ~40 years is later than that seen in multiple sclerosis. For MOG-antibody disease, its gender ratio is closer to 1:1, and it is more common in children than in adults. Its clinical phenotypes differ but overlap with those of AQP4-antibody disease and include acute disseminated encephalomyelitis, brainstem and cerebral cortical encephalitis, as well as optic neuritis and myelitis. Double-seronegative disease requires further research and clarification. Population-based studies over the past two decades report the prevalence and incidence of NMOSD in different populations worldwide. One relevant finding is the varying prevalence observed in different racial groups. Consistently, the prevalence of NMOSD among Whites is ~1/100,000 population, with an annual incidence of <1/million population. Among East Asians, the prevalence is higher, at ~3.5/100,000 population, while the prevalence in Blacks may be up to 10/100,000 population. For MOG-antibody disease, hospital-based studies largely do not observe any significant racial preponderance so far. This disorder comprises a significant proportion of NMOSD cases that are AQP4-antibody-seronegative. A recent Dutch nationwide study reported the annual incidence of MOG-antibody disease as 1.6/million population (adult: 1.3/million, children: 3.1/million). Clinical and radiological differences between AQP4-antibody and MOG-antibody associated diseases have led to interest in the revisions of NMOSD definition and expanded stratification based on detection of a specific autoantibody biomarker. More population-based studies in different geographical regions and racial groups will be useful to further inform the prevalence and incidence of NMOSD and their antibody-specific subgroups. Accessibility to AQP4-antibody and MOG-antibody testing, which is limited in many centers, is a challenge to overcome. Environmental and genetic studies will be useful accompaniments to identify other potential pathogenetic factors and specific biomarkers in NMOSD

Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSD

OBJECTIVE: To develop a resource of systematically collected, longitudinal clinical data and biospecimens for assisting in the investigation into neuromyelitis optica spectrum disorder (NMOSD) epidemiology, pathogenesis, and treatment. METHODS: To illustrate its research-enabling purpose, epidemiologic patterns and disease phenotypes were assessed among enrolled subjects, including age at disease onset, annualized relapse rate (ARR), and time between the first and second attacks. RESULTS: As of December 2017, the Collaborative International Research in Clinical and Longitudinal Experience Study (CIRCLES) had enrolled more than 1,000 participants, of whom 77.5% of the NMOSD cases and 71.7% of the controls continue in active follow-up. Consanguineous relatives of patients with NMOSD represented 43.6% of the control cohort. Of the 599 active cases with complete data, 84% were female, and 76% were anti-AQP4 seropositive. The majority were white/Caucasian (52.6%), whereas blacks/African Americans accounted for 23.5%, Hispanics/Latinos 12.4%, and Asians accounted for 9.0%. The median age at disease onset was 38.4 years, with a median ARR of 0.5. Seropositive cases were older at disease onset, more likely to be black/African American or Hispanic/Latino, and more likely to be female. CONCLUSION: Collectively, the CIRCLES experience to date demonstrates this study to be a useful and readily accessible resource to facilitate accelerating solutions for patients with NMOSD

Viral afterlife: SARS-CoV-2 as a reservoir of immunomimetic peptides that reassemble into proinflammatory supramolecular complexes

It is unclear how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection leads to the strong but ineffective inflammatory response that characterizes severe Coronavirus disease 2019 (COVID-19), with amplified immune activation in diverse cell types, including cells without angiotensin-converting enzyme 2 receptors necessary for infection. Proteolytic degradation of SARS-CoV-2 virions is a milestone in host viral clearance, but the impact of remnant viral peptide fragments from high viral loads is not known. Here, we examine the inflammatory capacity of fragmented viral components from the perspective of supramolecular self-organization in the infected host environment. Interestingly, a machine learning analysis to SARS-CoV-2 proteome reveals sequence motifs that mimic host antimicrobial peptides (xenoAMPs), especially highly cationic human cathelicidin LL-37 capable of augmenting inflammation. Such xenoAMPs are strongly enriched in SARS-CoV-2 relative to low-pathogenicity coronaviruses. Moreover, xenoAMPs from SARS-CoV-2 but not low-pathogenicity homologs assemble double-stranded RNA (dsRNA) into nanocrystalline complexes with lattice constants commensurate with the steric size of Toll-like receptor (TLR)-3 and therefore capable of multivalent binding. Such complexes amplify cytokine secretion in diverse uninfected cell types in culture (epithelial cells, endothelial cells, keratinocytes, monocytes, and macrophages), similar to cathelicidin’s role in rheumatoid arthritis and lupus. The induced transcriptome matches well with the global gene expression pattern in COVID-19, despite using <0.3% of the viral proteome. Delivery of these complexes to uninfected mice boosts plasma interleukin-6 and CXCL1 levels as observed in COVID-19 patients

Methodologies for <i>in vitro</i> and <i>in vivo</i> evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms.

Unlike superficial fungal infections of the skin and nails, which are the most common fungal diseases in humans, invasive fungal infections carry high morbidity and mortality, particularly those associated with biofilm formation on indwelling medical devices. Therapeutic management of these complex diseases is often complicated by the rise in resistance to the commonly used antifungal agents. Therefore, the availability of accurate susceptibility testing methods for determining antifungal resistance, as well as discovery of novel antifungal and antibiofilm agents, are key priorities in medical mycology research. To direct advancements in this field, here we present an overview of the methods currently available for determining (i) the susceptibility or resistance of fungal isolates or biofilms to antifungal or antibiofilm compounds and compound combinations; (ii) the &lt;i&gt;in vivo&lt;/i&gt; efficacy of antifungal and antibiofilm compounds and compound combinations; and (iii) the &lt;i&gt;in vitro&lt;/i&gt; and &lt;i&gt;in vivo&lt;/i&gt; performance of anti-infective coatings and materials to prevent fungal biofilm-based infections

Longitudinal retinal changes in MOGAD

OBJECTIVE: Patients with myelin oligodendrocyte glycoprotein antibody (MOG-IgG) associated disease (MOGAD) suffer from severe optic neuritis (ON) leading to retinal neuro-axonal loss, which can be quantified by optical coherence tomography (OCT). We assessed whether ON-independent retinal atrophy can be detected in MOGAD. METHODS: Eighty MOGAD patients and 139 healthy controls (HC) were included. OCT data was acquired with 1) Spectralis spectral domain OCT (MOGAD (N=66) and HC (N=103)) and 2) Cirrus HD-OCT (MOGAD (N=14) and HC (N=36)). Macular combined ganglion cell and inner plexiform layer (GCIPL) and peripapillary retinal nerve fibre layer (pRNFL) were quantified. RESULTS: At baseline, GCIPL and pRNFL were lower in MOGAD eyes with a history of ON (MOGAD-ON) compared with MOGAD eyes without a history of ON (MOGAD-NON) and HC (p12 months ago (p<0.001). The overall MOGAD cohort did not exhibit faster GCIPL thinning compared with HC. INTERPRETATION: Our study suggests the absence of attack-independent retinal damage in MOGAD. Yet, ongoing neuroaxonal damage or oedema resolution seems to occur for up to 12 months after ON, which is longer than what has been reported with other ON forms. These findings support that the pathomechanisms underlying optic nerve involvement and the evolution of OCT retinal changes after ON is distinct in MOGAD. This article is protected by copyright. All rights reserved

Retinal optical coherence tomography in neuromyelitis optica

BACKGROUND AND OBJECTIVES: To determine optic nerve and retinal damage in aquaporin-4 antibody (AQP4-IgG)-seropositive neuromyelitis optica spectrum disorders (NMOSD) in a large international cohort after previous studies have been limited by small and heterogeneous cohorts. METHODS: The cross-sectional Collaborative Retrospective Study on retinal optical coherence tomography (OCT) in neuromyelitis optica collected retrospective data from 22 centers. Of 653 screened participants, we included 283 AQP4-IgG-seropositive patients with NMOSD and 72 healthy controls (HCs). Participants underwent OCT with central reading including quality control and intraretinal segmentation. The primary outcome was thickness of combined ganglion cell and inner plexiform (GCIP) layer; secondary outcomes were thickness of peripapillary retinal nerve fiber layer (pRNFL) and visual acuity (VA). RESULTS: Eyes with ON (NMOSD-ON, N = 260) or without ON (NMOSD-NON, N = 241) were assessed compared with HCs (N = 136). In NMOSD-ON, GCIP layer (57.4 ± 12.2 μm) was reduced compared with HC (GCIP layer: 81.4 ± 5.7 μm, p < 0.001). GCIP layer loss (-22.7 μm) after the first ON was higher than after the next (-3.5 μm) and subsequent episodes. pRNFL observations were similar. NMOSD-NON exhibited reduced GCIP layer but not pRNFL compared with HC. VA was greatly reduced in NMOSD-ON compared with HC eyes, but did not differ between NMOSD-NON and HC. DISCUSSION: Our results emphasize that attack prevention is key to avoid severe neuroaxonal damage and vision loss caused by ON in NMOSD. Therapies ameliorating attack-related damage, especially during a first attack, are an unmet clinical need. Mild signs of neuroaxonal changes without apparent vision loss in ON-unaffected eyes might be solely due to contralateral ON attacks and do not suggest clinically relevant progression but need further investigation

Cohort profile: a collaborative multicentre study of retinal optical coherence tomography in 539 patients with neuromyelitis optica spectrum disorders (CROCTINO)

PURPOSE: Optical coherence tomography (OCT) captures retinal damage in neuromyelitis optica spectrum disorders (NMOSD). Previous studies investigating OCT in NMOSD have been limited by the rareness and heterogeneity of the disease. The goal of this study was to establish an image repository platform, which will facilitate neuroimaging studies in NMOSD. Here we summarise the profile of the Collaborative OCT in NMOSD repository as the initial effort in establishing this platform. This repository should prove invaluable for studies using OCT to investigate NMOSD. PARTICIPANTS: The current cohort includes data from 539 patients with NMOSD and 114 healthy controls. These were collected at 22 participating centres from North and South America, Asia and Europe. The dataset consists of demographic details, diagnosis, antibody status, clinical disability, visual function, history of optic neuritis and other NMOSD defining attacks, and OCT source data from three different OCT devices. FINDINGS TO DATE: The cohort informs similar demographic and clinical characteristics as those of previously published NMOSD cohorts. The image repository platform and centre network continue to be available for future prospective neuroimaging studies in NMOSD. For the conduct of the study, we have refined OCT image quality criteria and developed a cross-device intraretinal segmentation pipeline. FUTURE PLANS: We are pursuing several scientific projects based on the repository, such as analysing retinal layer thickness measurements, in this cohort in an attempt to identify differences between distinct disease phenotypes, demographics and ethnicities. The dataset will be available for further projects to interested, qualified parties, such as those using specialised image analysis or artificial intelligence applications